Attention Gates Foundation: Alsa Refinish Requests Your Help to Reduce Needle Use Worldwide The world desperately needs your committed help in partnering with an innovative therapeutic administration technology offering ultimate portability, stability and eliminating the need for needles.
LOS ANGELES, Jan. 9, 2014 /PRNewswire/ -- Inhalation technologies optimized from innovations similar to the common vaporizer/E-Cigarette can be used to effectively administer a wide range of therapeutics from small molecule drugs, nutritional supplements, NSAIDs to vaccines, all through a non-invasive, deep inhalation administration.
Please work with us to help distribute this technology for further testing, so that we can effectively bring therapeutic relief and optimized health to the far corners of the world. This simple and ground breaking technology will offer acute access and therapeutic relief to the world-wide population, in a portable and cost effective platform. Fine vapor particles (fine steam) in itself, developed from this technology, has also shown to bring relief to symptomatic respiratory distress. Therapeutic loading of this technology will offer limitless application potential.
We desperately need the attention of the Gates Foundation to offer guidance and support of our technology to impact world health. We are slowly gaining momentum:
We urgently plead with you to contact us at email@example.com so that we can work together in eradicating human suffering, and provide prophylactive health to so many areas in distress.
About Alsa Refinish LLC: Alsa Refinish LLC's team of talented chemists and pharmaceutical experts are specialists in innovative research and development. Over its 20-year history, the company has partnered with companies like GE to deliver high-quality products and services.
Contact name: Ike Banoun
Email address: firstname.lastname@example.org
Telephone number: 323-581-5200
Web site: TheV-Meds.com
SOURCE Alsa Refinish LLC